Skip to content

Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer

Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02338102
Enrollment
36
Registered
2015-01-14
Start date
2013-01-31
Completion date
2015-05-31
Last updated
2015-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis, Nasal Obstruction, Rhinitis, Vasomotor

Brief summary

The purpose of this study is to learn whether nasal saline irrigation is beneficial to patients undergoing radiation therapy for oropharyngeal cancer.

Detailed description

In this study, subjects are randomized to one of two study arms. They are either randomized to receive nasal saline irrigation treatment (treatment group) or not to receive any nasal irrigation treatment (control group). Subjects randomized to the treatment group will be provided with saline packets to mix with water. All study subjects will be asked to complete questionnaires during the study. If a subject completes all study related activities, their total length of participation in the study will last about 2 months.

Interventions

OTHERSaline mixture

premeasured salt packets mixed with distilled water

Sponsors

Lisa Shnayder
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients seen in the KUMC Ear, Nose and Throat clinic with oropharyngeal cancer that have undergone radiation therapy as the primary treatment

Exclusion criteria

* Patients that are at high risk for infection secondary to nasal irrigation * Patients with autoimmune disease or immune deficiency

Design outcomes

Primary

MeasureTime frameDescription
Change in quality of life, measured using Sino-Nasal Outcome Test (SNOT-20) summary scoresChange from Baseline to Month 2Outcome measured using Sino-Nasal Outcome Test (SNOT-20) summary scores. Scores will be collected at the baseline visit and again on the Month 2 visit. Outcome represented as a change in mean summary scores between the two visits. Scores can range from 0-5 with 0 being the best and 5 being the worst.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026